Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
November 16, 2025
 · 
Be the first to react
T-Cell Lymphoma: An Overview Read Article...
MyLymphomaTeam

It sounds like you're looking for information and connection around angioimmunoblastic T-cell lymphoma (AITL), which is understandably challenging since it's a rare form of lymphoma. You're not alone in this journey.

AITL is a rare type of peripheral T-cell lymphoma that typically affects adults, especially those over 70 Show Full Answer

It sounds like you're looking for information and connection around angioimmunoblastic T-cell lymphoma (AITL), which is understandably challenging since it's a rare form of lymphoma. You're not alone in this journey.

AITL is a rare type of peripheral T-cell lymphoma that typically affects adults, especially those over 70. It's a fast-growing cancer that primarily involves lymph nodes and bone marrow, though it can also affect the liver and spleen.

Since your wife has started CHOP chemotherapy, here's what you should know:

About CHOP Treatment:
CHOP is a standard first-line chemotherapy regimen for AITL that combines:
- Cytoxan (cyclophosphamide)
- Adriamycin (doxorubicin)
- Oncovin (vincristine)
- Prednisone (a corticosteroid)

CHOP has a high response rate of 70-80 percent for AITL, which is encouraging.

Other Treatment Options:
If needed down the road, doctors may consider:
- Adding targeted therapy like Adcetris to chemotherapy
- High-dose chemotherapy followed by stem cell transplantation
- Clinical trials for rare lymphomas like AITL

Important to Know:
AITL is often diagnosed at advanced stages, and stem cell transplantation can increase five-year progression-free survival rates to 40 percent when combined with chemotherapy.

Palliative care is also an important part of treatment to manage symptoms and maintain quality of life throughout treatment.

November 16, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Sarasota, FL

A MyLymphomaTeam Member asked a question 💭
Huntsville, AL